Saad-Ganem A, Alanís-Fuentes J, Salazar López-Ortiz CG, Muradas-Gil L, Quintero-Bernal P, Palma-Dorantes J, Charua LE

Language: Spanish
References: 12
Page: 448-453
PDF size: 931.93 Kb.

ABSTRACT

Background: The Essure® contraceptive device consists of a titanium and nickel coiled spring containing Dacron fibers. It is placed under hysteroscopic visualizaron in the proximal section of the Fallopian tube. The microinsert acts by inducing a tissue reaction that permanently blocks the tube within three months.
Objective: Show our experience in the use and insertion of the Essure^® device, in a prívate office.
Methods: We reviewed insertion procedure, complications, degree of tolerance and acceptance by user. Between June 2008 and May 2013 fifty cases with Essure® placement were made in our office.
Results: The average age was 36 years, as for the average number of pregnancies was two. The procedure time average was 6 minutes 25 seconds, no intraoperative complication was reported. All patients expressed very good tolerance and high degree of satisfaction with the procedure. A simple abdominal radiography was performed three months after the hysteroscopy to demónstrate the correct placement and position of the device, in all patients.
Conclussion: The number of patients is enough to show the advantages of the method and the possibility of performing it in an ambulatory environment, as it can be a prívate office with the correct equipment to do it.

REFERENCES

1. Valle R, Caringnan C, Wrigth T. The STOP prehysterectomy investigation group. Tissue response to the STOP microcoil trascervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril 2001;76:974-980.

2. Rios-Castillo J, Velasco E, Arjona-Berral J. Efficacy of Essure hysteroscopic sterilization-5 years follow up of 1200 women. Gynecol Endocrin 2012;29:580-582.

3. Thiel A, Carson G. Cost-Effectiveness analiysis Comparing the Essure Tubal Sterilization Procedure and Laparoscopic Tubal Sterilization. JOCG 2008;67:581-585.

4. Miño M, Arjona J, Pelegrin B, Provedano B, Chacón E. Success rate and patient satisfaction with the Essure sterilization in an outpatient setting: a prospective study of 857 women. BJOG 2007;89:763-766.

5. Kevin JF, Carigan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure clinical study. Aust N Z Obstet Gynecol 2001;41:364.

6. Úbeda A, Labastida R, Dexeus S. Essure: A new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril 2004;33:221.

7. Kerin JF, Cooper JM, Price T, Van Herendael B, Cayuela-Font E, Cher D, Carignan CS. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003;108:1223-1230.

8. Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure placement: report of two cases. Fertil Steril 2008;89:9-11.

9. Basinski, C. A Review of Clinical Data for Currently Approved Hysteroscopic Sterilization Procedures. Med Reviews 2010;11:101-110.

10. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997;336:762-767.

11. Avendaño B, Cruz M, Rojas P. Anticoncepción por histeroscopia. Una nueva alternativa. An Med 2009;54:215-221.

12. Duffy S, Marsh F, Rogerson L, Hudson H. Female sterilization: a cohort controlled comparative study of ESSURE versus laparoscopic sterilization. BJOG 2005;112:1522- 1528.